Effect of Helicobacter pylori eradication on iron deficiency

Chinese Medical Journal

Volumn 123, Issue 14, 2010, Pages 1924-1930

  Zhang, Zhi Feng ^a   Yang, Ning ^a   Zhao, Gang ^a   Zhu, Lei ^a   Zhu, Ying ^a   Wang, Li Xia ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Helicobacter pylori; Iron deficiency; Meta analysis

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; FERRITIN; FERROUS SUCCINATE; FERROUS SULFATE; HEMOGLOBIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ERADICATION THERAPY; FERRITIN BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON THERAPY; META ANALYSIS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

ANEMIA, IRON-DEFICIENCY; ANIMALS; ANTI-BACTERIAL AGENTS; HELICOBACTER INFECTIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78649576923     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.14.017     Document Type: Article

References (44)

1. World prevalence of anemia 1993-2005. WHO Global Database on Anemia. Geneva, World Health Organization, 2008. (Accessed September 14, 2008 at http://www.who.int/vmnis/anaemia/prevalence/en/.)
2. Iron deficiency anemia: assessment, prevention, and control. A guide for program managers. Geneva, World Health Organization, 2001. (Accessed September 14, 2001 at http://whqlibdoc.who.int/hq/2001/WHO_NHD_01.3.pdf.)
3. Cogswell ME, Looker AC, Pfeiffer CM, Cook JD, Lacher DA, Beard JL, et al. Assessment of iron deficiency in US preschool children and nonpregnant females of childbearing age: National Health and Nutrition Examination Survey 2003-2006. Am J Clin Nutr 2009; 89: 1334-1342.
4. Heath AL, Fairweather-Tait SJ. Clinical implications of changes in the modern diet: iron intake, absorption and status. Best Pract Res Clin Haematol 2002; 15: 225-241.
5. Ma G, Jin Y, Li Y, Zhai F, Kok FJ, Jacobsen E, et al. Iron and zinc deficiencies in China: what is a feasible and cost-effective strategy? Public Health Nutr 2008; 11: 632-638.
6. Arlappa N, Balakrishna N, Laxmaiah A, Brahmam GN. Prevalence of anemia among rural pre-school children of West Bengal, India. Ann Hum Bio 2009; 4: 1-12.
7. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004; 110: 149-154.
8. Reid DW, Withers NJ, Francis L, Wilson JW, Kotsimbos TC. Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest 2002; 121: 48-54.
9. Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J Nutr 2001; 131: 604S-614S; discussion 614S-615S.
10. Hurtado EK, Claussen AH, Scott KG. Early childhood anemia and mild or moderate mental retardation. Am J Clin Nutr 1999; 69: 115-119.
11. Idjradinata P, Pollitt E. Reversal of developmental delays in iron-deficient anaemic infants treated with iron. Lancet 1993; 341: 1-4.
12. Zimmermann MB, Chaouki N, Hurrell RF. Iron deficiency due to consumption of a habitual diet low in bioavailable iron: a longitudinal cohort study in Moroccan children. Am J Clin Nutr 2005; 81: 115-121.
13. Hurrell RF, Lynch S, Bothwell T, Cori H, Glahn R, Hertrampf E, et al. Enhancing the absorption of fortification iron. A SUSTAIN Task Force report. Int J Vitam Nutr Res 2004; 74: 387-401.
14. Baggett HC, Parkinson AJ, Muth PT, Gold BD, Gessner BD. Endemic iron deficiency associated with Helicobacter pylori infection among school-aged children in Alaska. Pediatrics 2006; 117: e396-e404.
15. Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol 2006; 163: 127-134.
16. Muhsen K, Cohen D. Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 2008; 13: 323-340.
17. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. (Accessed at http://www.cochrane-handbook.org.)
18. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement: Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-1900.
19. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. J Med Libr Assoc 2006; 94: 130-136.
20. Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg PA, Hultén L. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol 1993; 85: 787-798.
21. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev 2009; 23: 95-104.
22. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781.
23. Richter JE. Oesophageal motility disorders. Lancent 2001; 358: 823-828.
24. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
25. Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale, OK: Lawrence Erlbaum Assoc; 1988.
26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
27. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999; 18: 2693-2708.
28. Chen LH, Luo HS. Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastritis. World J Gastroenterol 2007; 13: 5380-5383.
29. Gessner BD, Baggett HC, Muth PT, Dunaway E, Gold BD, Feng Z, et al. A controlled, household-randomized, open-label trial of the effect that treatment of Helicobacter pylori infection has on iron deficiency in children in rural Alaska. J Infect Dis 2006; 193: 537-546.
30. Fagan RP, Dunaway CE, Bruden DL, Parkinson AJ, Gessner BD. Controlled, household-randomized, open-label trial of the effect of treatment of Helicobacter pylori infection on iron deficiency among children in rural Alaska: results at 40 months. J Infect Dis 2009; 199: 652-660.
31. Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Randomized placebo-controlled trial of helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter 1999; 4: 135-139.
32. Sarker SA, Mahmud H, Davidsson L, Alam NH, Ahmed T, Alam N, et al. Causal relationship of Helicobacter pylori with iron-deficiency anemia or failure of iron supplementation in children. Gastroenterology 2008; 135: 1534-1542.
33. Cheng JM. The necessity of anti-helicobacter pylori therapy on iron deficiency anemia in children. Contemp Med (Chin) 2008; 143: 36-37.
34. Lin Y, Wang WG, Wang SZ. Treatment of iron-deficiency anemia in patients with concomitant Helicobacter pylori infection: experience of 68 cases. Chin J Contemp Pediatr (Chin) 2005; 7: 429-431.
35. Hu PQ. Analysis of the effectiveness of anti-helicobacter pylori therapy on iron deficiency anemia. J Henan Med Coll Staff Workers (Chin) 2007; 19: 340-342.
36. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007; 370: 511-520.
37. Hallberg L. Combating iron deficiency: daily administration of iron is far superior to weekly administration. Am J Clin Nutr 1998; 68: 213-217.
38. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282: 1054-1060.
39. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-488.
40. Champagne ET. Low gastric hydrochloric acid secretion and mineral bioavailability. Adv Exp Med Biol 1989; 249: 173-184.
41. Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 2003; 52: 496-501.
42. Tonello F, Dundon WG, Satin B, Molinari M, Tognon G, Grandi G, et al. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol Microbiol 1999; 34: 238-246.
43. Pietroiusti A, Galante A, Magrini A, Bergamaschi A. Helicobacter pylori interference with micronutrients and orally administered drugs: a new mechanism explaining its role in extragastric disorders. Mini Rev Med Chem 2008; 8: 135-141.
44. Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol 2004; 99: 1833-1855.